When Hannah McKinley walked into her local emergency department in July 2017 struggling to breathe, she was 26 years old. She lived a fairly carefree life, working in customer service and hanging out with friends on weekends. She received a diagnosis that would redefine her life. A CT scan revealed a mass in her throat….
A new radiation technology is helping make treatments faster, more comfortable and safer for patients at Norton Cancer Institute. ExacTrac Dynamic, developed by Brainlab, is a motion-tracking and patient positioning system that improves accuracy during radiation therapy, supporting stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) across a range of cancer types. How ExacTrac…
Norton Cancer Institute has added significant clinical oncology research expertise with the arrival of Kevin T. Breen, M.D., Ph.D., who is expected to become one of the new leaders of Norton Cancer Institute’s early-phase clinical trials program. Dr. Breen brings specialized knowledge in brain cancer immunotherapy from his previous work at the National Institutes of…
Norton Cancer Institute’s gynecologic oncology research program continues to expand rapidly, helping address a critical regional gap in specialty treatment and clinical research access. Nationally, gynecologic oncology is heavily driven by early phase trials, underscoring the need for programs that advance novel therapies and accelerate progress in treatment options. Our current gynecologic oncology studies include…
Life-changing, advanced cancer technology has arrived at Norton Audubon Hospital for patients with pancreatic cancer. William B. Evans III, M.D., gastroenterologist with Norton Gastroenterology Consultants of Louisville, recently became the first and only physician in Kentucky to perform endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for pancreatic cancer. “It’s an honor to be the first in the state to…
Recent advances in colonoscopy techniques are helping physicians detect more colon cancers while reducing complications, according to updated medical guidelines that emphasize quality indicators and improved detection methods. William B. Evans III, M.D., gastroenterologist with Norton Gastroenterology Consultants of Louisville, presented the findings at a continuing medical education session, outlining key changes in how physicians…
The patient A 75-year-old male presented with a left neck mass, referred by his community otolaryngologist. The patient reported a history of sleep apnea, cough and recurrent upper respiratory infections. Imaging and fine needle aspiration of the neck mass confirmed p16 positive squamous cell carcinoma (SCC). Positron emission tomography (PET)/CT demonstrated a hypermetabolic left level…
The multidisciplinary Norton Children’s Cancer Predisposition Program is designed to identify, monitor and support children who have inherited genetic conditions that increase their lifetime risk of cancer. The program established in November 2024 is a collaborative effort between Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, and Norton Children’s Genetics Center, also…
Cancer care offered through Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, is ranked among the top 50 pediatric cancer programs nationwide by U.S. News & World Report in its 2024–2025 Best Children’s Hospitals rankings. This recognition reflects the commitment to excellence at Norton Children’s Cancer Institute, evident in a comprehensive array…
Mustafa Barbour, M.D., pediatric neuro-oncologist with Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, is working to advance pediatric neuro-oncology care in Kentucky, where the incidence of pediatric brain tumors exceeds the national average. In response, Dr. Barbour, who leads the Norton Children’s Brain & Spinal Tumor program, helps lead new research…
After improving pediatric cancer survival from nearly nil in the 1950s to more than 85% today, health care providers face new challenges, especially long-term cognitive deficits associated with chemotherapy. In addition to attacking cancer cells, chemotherapy also can affect healthy cells, including those in the central nervous system. This can lead to a range of…
Pediatric oncology’s remarkable strides improving survival for children with cancer also has brought a new set of long-term health implications.